GlassScriptPhysician profile
Chad M Mckenzie
NPI 1114925500
$12,998.45
in general payments reported to CMS, 2019-2025
42 companies · $4,846 in 2025
The $4,846 reported for 2025 was more than what 84% of Vascular Surgery providers received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,978 · 2020: $1,258 · 2021: $1,369 · 2022: $1,795 · 2023: $612 · 2024: $1,139 · 2025: $4,846.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,127 · Food and Beverage: $2,471.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,127.31 |
| Food and Beverage | $2,470.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $6,431.39 | 2021-2025 | Endurant Iis |
| Abbott Laboratories | $917.75 | 2019-2024 | Esprit |
| Endologix LLC | $823.23 | 2020-2024 | Endocross Device, Torus Stent Graft System, Alto Abdominal Stent Graft System |
| Janssen Pharmaceuticals, INC | $717.36 | 2019-2024 | Xarelto |
| Boston Scientific Corporation | $703.38 | 2019-2025 | Opticross 35, Eluvia, Ekosonic |
| Medtronic Vascular, INC. | $504.03 | 2019-2020 | |
| Bard Peripheral Vascular, INC. | $262.58 | 2019-2025 | Fluency Endovascular Stent Graft, Trek, Covera |
| Silk Road Medical, INC. | $253.04 | 2020-2022 | |
| Nuvasive, INC. | $250.35 | 2019 | |
| Stryker Corporation | $219.53 | 2019-2023 | Lite Plate System |
| Cardiovascular Systems INC. | $180.44 | 2019-2021 | |
| Shockwave Medical, INC | $176.37 | 2021-2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Smith+Nephew, INC. | $136.98 | 2019-2023 | Collagenase Santyl, Iodosorb Ointment 40g USA |
| Reflow Medical INC | $108.97 | 2024 | |
| Pfizer INC. | $102.83 | 2019-2025 |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chad Mckenzie listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.